Attacking MRSA with metals from antibacterial clays

In the race to protect society from infectious microbes, the bugs are outrunning us. The need for new therapeutic agents is acute, given the emergence of novel pathogens as well as old foes bearing heightened antibiotic resistance.

New molecule heralds hope for muscular dystrophy treatment

(Phys.org) —There's hope for patients with myotonic dystrophy. A new small molecule developed by researchers at the University of Illinois has been shown to break up the protein-RNA clusters that cause the disease in living ...

Lipid vesicles to replace mouse experiments

Researchers from ETH Zurich have filed a patent application for a method to test the biological activity of one of the strongest toxins known, the botulinum neurotoxin. If the procedure is adopted by the pharmaceutical industry, ...

Using viruses to beat superbugs

Viruses that can target and destroy bacteria have the potential to be an effective strategy for tackling hard-to-treat bacterial infections. The development of such novel therapies is being accelerated in response to growing ...

Sea sponge potential source of new medicines

The sea sponge has provided Flinders University researchers with inspiration for the discovery and development of new therapeutic agents in the treatment of infectious diseases and cancers.

page 2 from 3